SPOTLIGHT: FDA calls for Ketek warning
The FDA wants Sanofi-Aventis to put a warning label on the antibiotic Ketek that spells out concerns that the drug may be linked to liver failure. Sanofi insists the drug is safe and effective. Report
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
